Automated glycemic control with the bionic pancreas in cystic fibrosis-related diabetes: A pilot study

Cystic fibrosis-related diabetes (CFRD) is the most common extrapulmonary manifestation of cystic fibrosis. The current standard of care for CFRD involves treatment with insulin, typically via multiple daily injections. We conducted a small pilot study comparing usual care with automated glycemic control using the bihormonal (insulin and glucagon) and insulin-only configurations of the bionic pancreas. Both configurations of the bionic pancreas achieved good glycemic control, with mean glucose levels

Source: Journal of Cystic Fibrosis - August 12, 2019 Category: Respiratory Medicine Authors: Jordan S. Sherwood, Rabab Z. Jafri, Courtney A. Balliro, Hui Zheng, Firas H. El-Khatib, Edward R. Damiano, Steven J. Russell, Melissa S. Putman Tags: Short Communication Source Type: research